通过TET2介导的ECM1低甲基化促进了活性增殖性糖尿病视网膜病变的新血管化

Chunyang Cai1,2, Chufeng Gu1,2, Shuai He1,2

  • 1Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 100 Haining Road, Hongkou District, Shanghai, 200080, People's Republic of China.

Clinical epigenetics
|January 3, 2024
PubMed
概括

在糖尿病视网膜病变 (DR) 中失调的TET2通过减少像ECM1.1这样的基因的DNA甲基化来促进新血管化. 向TET2为增殖性糖尿病视网膜病变 (PDR) 提供了一种新的治疗方法.